Generic Drugmaker Sues FDA to Get Its Exclusivity Back
February 2, 2017
Dana A. Elfin
Pharmaceutical Law & Industry Report
Axinn partner Chad Landmon was quoted throughout the Pharmaceutical Law & Industry Report article, "Generic Drugmaker Sues FDA to Get Its Exclusivity Back." Click here to access the article.*
*Reproduced with permission from Pharmaceutical Law & Industry Report, 15 PLIR 155 (Feb. 3, 2017). Copyright 2017 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com